Company / SG&A per Share
Prime Medicine, Inc. SG&A per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.42
FY2024
5-year range
$0.42 / $1.20
FY2020-FY2024
Trend
-11.3%
vs FY2023
Sector context
#172 of 206
Health Care
What the data says
Prime Medicine, Inc.'s sg&a per share of $0.42 is lower than 83% of companies in the Health Care sector (FY2024). SG&A per Share has declined for 4 consecutive years, from $1.20 in FY2020 to $0.42 in FY2024.
Based on SEC 10-K filings.
0.42 in FY2024 with a 3-year CAGR of -26.7%.
Improved from $0.88 to $0.42 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -26.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 206This company $0.42 Sector average $44.68
▼
-99.1% below sector average
Key checks
Key Insights
- Prime Medicine, Inc.'s sg&a per share has declined for 4 consecutive years.
- In FY2024, sg&a per share decreased 11.3% year-over-year.
- Ranks #172 out of 206 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.24 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.42 | -11.3% |
| FY2023 | $0.48 | -45.8% |
| FY2022 | $0.88 | -18.0% |
| FY2021 | $1.07 | -10.4% |
| FY2020 | $1.20 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026